Scanfil’s Q1 2026 report is out.
Scanfil Q1 2026: Steady Start with Significant Revenue and Profit Improvement
January–March
• Revenue was EUR 229.1 million (192.6), up 19.0%
• Revenue grew organically by 6.5%
• Comparable EBITA margin was 6.8% (6.5%) and comparable EBITA was EUR 15.6 (12.6) million, up 24.1%
• Earnings per share were EUR 0.15 (0.13)
• Net debt/EBITDA was 1.57 (0.22)
• Dividend proposal EUR 0.25 (0.24) per share
CEO Christophe Sut:
“The first quarter of 2026 opens a new chapter for Scanfil. In terms of revenue, profit, and customer base, we are stronger than ever. In an era of increasing complexity in regionalization and supply chain management, Scanfil took a step forward in the first quarter, making us confident in achieving our 2026 targets.
At the turn of the year, we completed two strategically significant acquisitions that elevated Scanfil to a whole new level. The acquisition of ADCO Circuits was completed in December 2025, and the acquisition of MB Elettronica in January 2026. Both companies expand our global operations into new markets with strong growth potential and bring with them a robust customer portfolio in the Aerospace & Defense and Medtech & Life Science customer groups, which have positive long-term outlooks.
Revenue grew by 19.0% to EUR 229.1 million in the first quarter compared to the previous year. The positive momentum continued, with organic revenue growth of 6.5%. The development was as expected, based on strong new sales in the second half of 2025. Acquisitions increased revenue by 14% overall. MB, in particular, showed strong momentum and double-digit growth compared to the previous year.
Our EBITA margin increased by 0.3 percentage points to 6.8% compared to the previous year. The comparable EBITA margin was strong despite several ramp-ups of new customer projects and their impact on efficiency. MB also had a positive impact on the margin from the outset.
Revenue in the Americas grew organically by 12.3% in the first quarter compared to the previous year. Business prospects remained strong. In the first quarter, we achieved a record in the ramp-up of new customer projects. While these affected profitability in the first quarter, they built strong momentum for the second half of the year.
APAC revenue in the first quarter grew organically by 10.9% compared to the previous year. Customer demand and operational efficiency are strong. In January, we announced investments in our Chinese operations. These investments should be fully operational in 2027, at which point they will begin to support our development in the region.
Central Europe revenue grew organically by 2.9% in the first quarter compared to the previous year. Total revenue grew by 32.7% due to the acquisition of MB. Operations in Poland grew organically, but the operating environment in Germany remained challenging.
Northern Europe revenue grew organically by 5.6% in the first quarter compared to the previous year. Growth was supported by strong demand from our Aerospace & Defense customers.
Recent developments in the global geopolitical situation favor our customer group strategy. The energy sector is crucial for crisis resilience, and at the same time, the need for internal and external security is growing. Both trends have a positive impact on our Energy & Cleantech and Aerospace & Defense businesses. In the first quarter, the total value of new customer projects was EUR 51.7 million compared to EUR 46.7 million in the previous year.
Aerospace & Defense revenue grew by 130.5% to EUR 21.0 (9.1) million in the first quarter. Aerospace & Defense figures were reported for the first time as a separate customer group from Industrial. Most of the growth was due to acquisitions, but also from existing customers. In the first quarter, the total value of new customer projects was EUR 0.9 million.
Energy & Cleantech revenue grew by 18.8% in the first quarter compared to the previous year. Projects for new customers decreased by 3.7% to EUR 23.9 million. Underlying demand has remained strong.
Industrial revenue grew by 12.4% in the first quarter compared to the previous year. New customer projects increased by 0.7% to EUR 15.5 million year-on-year. The high revenue growth was due to acquisitions.
Medtech & Life Science revenue grew by 7.1% in the first quarter compared to the previous year. The number of new customer projects increased by 79.1% to EUR 11.5 million year-on-year. Revenue was boosted by acquisitions and investments in sales.
After the first quarter, our confidence strengthened. Our acquisitions are yielding results and supporting our strong organic growth. We estimate 2026 revenue to be EUR 940–1,060 million and comparable EBITA to be EUR 64–78 million. In January, we announced an investment in our Chinese operations, where demand has grown and prospects are positive. Our 2025 investments in Malaysia and the United States are in the commissioning phase and will start to have an impact during 2026.
We celebrate Scanfil’s 50th anniversary year with confidence. We want to thank our customers, partners, and employees for their strong trust and cooperation over the past 50 years.”
Full report: